Lukang Biochemical: Announcement on the progress of restarting share transfers, asset purchases and asset purchases
Lukang Biochemical: Announcement on the company's 2021 profit distribution plan
Lukang Biochemical: Notice on Responding to Feedback on Application Documents for the Public Issuance of Convertible Corporate Bonds
Lukang Biochemical: Notice on Receiving Feedback from the China Securities Regulatory Commission on Application Documents for the Public Issuance of Convertible Corporate Bonds
Lukang Biochemical: Announcement on the acceptance of the application for the public issuance of convertible corporate bonds by the China Securities Regulatory Commission
Lukang Biochemical: Feasibility Analysis Report on the Use of Funds Raised by the Public Issuance of Convertible Corporate Bonds
Lukang Biochemical: Announcement on Adjusting the Plan for the Public Issuance of Convertible Corporate Bonds
Lukang Biochemical: Feasibility Analysis Report on the Use of Funds Raised by the Public Issuance of Convertible Corporate Bonds
Lukang Biochemical: Announcement on the Public Issuance of Convertible Corporate Bonds to Dilute Immediate Returns and Compensatory Measures and Relevant Entities Effectively Fulfill Return Measures Commitments
Lukang Biochemical: Announcement on the controlling shareholder's securities financing business
Lukang Biochemical: Announcement on Launching Foreign Exchange Hedging Business
Announcement on the stock listing and transaction of Lukang Biochemical Co., Ltd.
Lukang Biochemical: China Securities Regulatory Commission\'s Approval on Approving the Company\'s Initial Public Offering of Shares
No Data
No Data